At the Research Awards 2024, we had the pleasure of hearing from Professor Anna DeFazio AM, University of Sydney, who heads ...

The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal ...

According to the Centers for Disease Control and Prevention ( CDC ), ovarian cancer may cause vaginal bleeding, pelvic pain, ...

Scroll down to know how chemotherapy, radiation, and surgery influence ovarian function, menopause, and hormonal balance.

Ovarian cancer is the deadliest gynecologic malignancy globally and is increasing in incidence and mortality with currently ...

Hyperthermic intraperitoneal chemotherapy (HIPEC) is an innovative treatment approach used in the management of ovarian cancer, particularly in advanced stages. This technique involves delivering ...

certain chemotherapy drugs can also raise risk for a secondary cancer. Chemotherapy for ovarian cancer typically includes a platinum-based drug, such as cisplatin or carboplatin. Your treatment ...

Ovarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm with the introduction ...

Global Ovarian Cancer Drugs Market size is expected to be worth around USD 9,857 Mn by 2032 from USD 3061 Mn in 2023, growing at a CAGR of 14.3% ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

In South Africa, the number of cases of ovarian cancer is predicted to rise by a staggering 72.9% by 2050, underscoring the ...

The "Ovarian Cancer Market by Type, by Diagnosis Scans, by Treatment, by End-user, and by Region" report has been added to ...